Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 2
1994 2
1995 1
1996 2
1997 1
1998 1
1999 2
2000 1
2001 1
2002 2
2003 2
2004 1
2005 3
2006 1
2007 1
2008 2
2010 3
2011 2
2013 1
2014 1
2016 1
2018 1
2020 1
2021 1
2022 2
2023 1
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for reguera jm
Search for Reguero JM instead (1 results)
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial.
Molina J, Montero-Mateos E, Praena-Segovia J, León-Jiménez E, Natera C, López-Cortés LE, Valiente L, Rosso-Fernández CM, Herrero M, Aller-García AI, Cano Á, Gutiérrez-Gutiérrez B, Márquez-Gómez I, Álvarez-Marín R, Infante C, Roca C, Valiente-Méndez A, Pachón J, Reguera JM, Corzo-Delgado JE, Torre-Cisneros J, Rodríguez-Baño J, Cisneros JM; SHORTEN trial team. Molina J, et al. Among authors: reguera jm. Clin Microbiol Infect. 2022 Apr;28(4):550-557. doi: 10.1016/j.cmi.2021.09.001. Epub 2021 Sep 9. Clin Microbiol Infect. 2022. PMID: 34508886 Free article. Clinical Trial.
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA).
Pérez-Galera S, Bravo-Ferrer JM, Paniagua M, Kostyanev T, de Kraker MEA, Feifel J, Sojo-Dorado J, Schotsman J, Cantón R, Daikos GL, Carevic B, Dragovac G, Tan LK, Raka L, Hristea A, Viale P, Akova M, Reguera JM, Valiente de Santis L, Torre-Cisneros J, Cano Á, Roilides E, Radulovic L, Kirakli C, Shaw E, Falagas ME, Pintado V, Goossens H, Bonten MJ, Gutiérrez-Gutiérrez B, Rodriguez-Baño J; COMBACTE-CARE-EURECA Team. Pérez-Galera S, et al. Among authors: reguera jm. EClinicalMedicine. 2023 Feb 27;57:101871. doi: 10.1016/j.eclinm.2023.101871. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 36895801 Free PMC article.
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.
Zhou H, Buetti N, Pérez-Galera S, Bravo-Ferrer J, Gutiérrez-Gutiérrez B, Paniagua-García M, Feifel J, Sauser J, Kostyanev T, Canton R, Tan LK, Basoulis D, Pintado V, Roilides E, Dragovac G, Torre-Cisneros J, Mediç D, Akova M, Goossens H, Bonten M, Harbarth S, Rodriguez-Baño J, De Kraker MEA; COMBACTE- EURECA project team. Zhou H, et al. J Antimicrob Chemother. 2024 Sep 3;79(9):2132-2141. doi: 10.1093/jac/dkae157. J Antimicrob Chemother. 2024. PMID: 38988305 Free PMC article.
How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations.
Fernández-Ruiz M, Castón JJ, Del Pozo JL, Carratalà J, Fortún J, Salavert M, Torre-Cisneros J, Aguado JM; members of the OPENIN (Optimización de procesos clínicos para el diagnóstico y tratamiento de infecciones) Group; Fernández Cruz A, Ventura A, Loeches B, Dueñas C, Tomás C, Navarro D, Oltra R, Resino-Foz E, García Vázquez E, Míguez E, Merino E, Braojos F, Martínez FJ, López-Medrano Pérez F, Machuca I, Cobo J, López Contreras J, Reguera JM, Ruiz Mesa JD, Tiraboschi J, Abella L, Masiá M, Del Toro López MD, Díaz López MD, Carrasco-Antón N, Merchante N, Muñoz P, Torres R, Rodríguez R, Mata-Forte T, Abril V. Fernández-Ruiz M, et al. Among authors: reguera jm. Enferm Infecc Microbiol Clin (Engl Ed). 2024 Oct;42(8):442-452. doi: 10.1016/j.eimce.2024.07.001. Epub 2024 Aug 6. Enferm Infecc Microbiol Clin (Engl Ed). 2024. PMID: 39112116 Free article. Review.
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA).
Paniagua-García M, Bravo-Ferrer JM, Pérez-Galera S, Kostyanev T, de Kraker MEA, Feifel J, Palacios-Baena ZR, Schotsman J, Cantón R, Daikos GL, Carevic B, Dragovac G, Tan LK, Raka L, Hristea A, Viale P, Akova M, Cano Á, Reguera JM, Bartoloni A, Florescu SA, Benea S, Bukarica L, Asensio Á, Korten V, Grundmann H, Goossens H, Bonten MJ, Gutiérrez-Gutiérrez B, Rodríguez-Baño J; COMBACTE-CARE-EURECA team. Paniagua-García M, et al. Among authors: reguera jm. Clin Microbiol Infect. 2024 Feb;30(2):223-230. doi: 10.1016/j.cmi.2023.11.008. Clin Microbiol Infect. 2024. PMID: 38267096 Free article.
Cellular stress modulates severity of the inflammatory response in lungs via cell surface BiP.
Rico-Llanos G, Porras-Perales Ó, Escalante S, Vázquez-Calero DB, Valiente L, Castillo MI, Pérez-Tejeiro JM, Baglietto-Vargas D, Becerra J, Reguera JM, Duran I, Csukasi F. Rico-Llanos G, et al. Among authors: reguera jm. Front Immunol. 2022 Nov 18;13:1054962. doi: 10.3389/fimmu.2022.1054962. eCollection 2022. Front Immunol. 2022. PMID: 36466830 Free PMC article.
Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy.
Mensa J, Barberán J, Soriano A, Llinares P, Marco F, Cantón R, Bou G, González Del Castillo J, Maseda E, Azanza JR, Pasquau J, García-Vidal C, Reguera JM, Sousa D, Gómez J, Montejo M, Borges M, Torres A, Alvarez-Lerma F, Salavert M, Zaragoza R, Oliver A. Mensa J, et al. Among authors: reguera jm. Rev Esp Quimioter. 2018 Feb;31(1):78-100. Epub 2018 Feb 23. Rev Esp Quimioter. 2018. PMID: 29480677 Free PMC article. Review.
Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis.
Hidalgo-Tenorio C, Gálvez J, Martínez-Marcos FJ, Plata-Ciezar A, De La Torre-Lima J, López-Cortés LE, Noureddine M, Reguera JM, Vinuesa D, García MV, Ojeda G, Luque R, Lomas JM, Lepe JA, de Alarcón A. Hidalgo-Tenorio C, et al. Among authors: reguera jm. BMC Infect Dis. 2020 Feb 21;20(1):160. doi: 10.1186/s12879-020-4895-1. BMC Infect Dis. 2020. PMID: 32085732 Free PMC article.
Posttreatment follow-Up of brucellosis by PCR assay.
Morata P, Queipo-Ortuño MI, Reguera JM, García-Ordoñez MA, Pichardo C, Colmenero JD. Morata P, et al. Among authors: reguera jm. J Clin Microbiol. 1999 Dec;37(12):4163-6. doi: 10.1128/JCM.37.12.4163-4166.1999. J Clin Microbiol. 1999. PMID: 10565954 Free PMC article.
Osteoarticular complications of brucellosis.
Colmenero JD, Reguera JM, Fernández-Nebro A, Cabrera-Franquelo F. Colmenero JD, et al. Among authors: reguera jm. Ann Rheum Dis. 1991 Jan;50(1):23-6. doi: 10.1136/ard.50.1.23. Ann Rheum Dis. 1991. PMID: 1994863 Free PMC article.
43 results